AA
RMD icon

Ancora Advisors’s ResMed RMD Stock Holding History

Ancora Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-102
Closed -$22.9K – 2304
2026
Q1 		$22.9K Buy
102
+23
+29% +$5.73K ﹤0.01% 1488
2025
Q4 		$19K Buy
79
+78
+7,800% +$19.9K ﹤0.01% 1577
2025
Q3 		$274 Hold
1
– – ﹤0.01% 1880
2025
Q2 		$258 Hold
1
– – ﹤0.01% 1883
2025
Q1 		$224 Hold
1
– – ﹤0.01% 1695
2024
Q4 		$229 Hold
1
– – ﹤0.01% 1725
2024
Q3 		$244 Buy
+1
New +$223 ﹤0.01% 1684
2023
Q1 		– Sell
-2
Closed – – 2040
2022
Q4 		$0 Buy
+2
New +$439 ﹤0.01% 1923

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ancora Advisors's RMD Position: Q2 2026 in Review

Ancora Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 102 shares — an estimated $22.9K sold.

Ancora Advisors first reported a position in RMD in Q4 2022 and held it in 8 quarters. The position peaked at $22.9K in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ancora Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 102 ResMed shares in Q2 2026, an estimated $22.9K.
  • Ancora Advisors first reported a position in ResMed in Q4 2022 and held it in 8 quarters.
  • Ancora Advisors's ResMed position peaked at $22.9K in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.